Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Chairperson's File
We know that health equity matters. But what exactly does the term mean? AHA’s Institute for Diversity and Health Equity defines “health equity” as “The fair…
Headline
The AHA’s Hospital Community Collaborative has released "Healthier Together," a report about the program’s impact on community health throughout the country.…
Blog
The greatest success story of the 20th century is longevity. This is especially true in the United States, where average life expectancy at birth rose by more…
Headline
The Centers for Medicare & Medicaid Services July 10 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Chairperson's File
Hospitals and health systems have a long history of leading initiatives that improve individual and community health. By partnering with community-based…
Headline
The Department of Health and Human Services July 2 announced it will provide Medicaid and Children's Health Insurance Program coverage to incarcerated people…